Perrigo (PRGO) Amortizatization of Intangibles (2017 - 2026)
Perrigo's (PRGO) quarterly Amortizatization of Intangibles came in at $2.2 million in Q1 2026, little changed year-on-year from $2.2 million in Q1 2025, and down 4.35% on a QoQ basis from $2.3 million in Q4 2025.
Perrigo (PRGO) Amortizatization of Intangibles (2017 - 2026) Analysis & Trends
Perrigo (PRGO) has 10 years of Amortizatization of Intangibles data on file, last reported at $2.2 million in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles changed 0.0% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $9.0 million, a 15.89% decrease from a year earlier, with the FY2025 full-year figure at $9.0 million, up 1.12% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $2.2 million, down from $2.3 million in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for PRGO reached as high as $7.8 million in Q4 2024 and fell as low as -$4.1 million in Q3 2022.
- Historically, Amortizatization of Intangibles has averaged $1.3 million across 5 years, with a median of $700000.0 in 2023.
- Across the five-year window, Amortizatization of Intangibles sank 485.71% in 2022 and soared 1460.0% in 2024, its largest moves.
- Year by year, Amortizatization of Intangibles stood at $2.1 million in 2022, then tumbled by 76.19% to $500000.0 in 2023, then surged by 1460.0% to $7.8 million in 2024, then slumped by 70.51% to $2.3 million in 2025, then decreased by 4.35% to $2.2 million in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $2.2 million in Q1 2026, $2.3 million in Q4 2025, and $2.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Perrigo | 1.42 Bn | 1.06 Bn | 325.50 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 2.20 Mn |
| Mar 28, 2026 | 2.20 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Dec 31, 2025 | 2.30 Mn |
| Sep 27, 2025 | 2.30 Mn |
| Sep 27, 2025 | 2.30 Mn |
| Jun 28, 2025 | 2.20 Mn |
| Jun 28, 2025 | 2.20 Mn |
| Mar 29, 2025 | 2.20 Mn |
| Mar 29, 2025 | 2.20 Mn |
| Dec 31, 2024 | 7.80 Mn |
| Dec 31, 2024 | 7.80 Mn |
| Sep 28, 2024 | 400,000.00 |
| Sep 28, 2024 | 400,000.00 |
| Jun 29, 2024 | 300,000.00 |
| Jun 29, 2024 | 300,000.00 |
| Mar 30, 2024 | 400,000.00 |
| Mar 30, 2024 | 400,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |